| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |